Roche opens up new possibilities for genomic research in Asia Pacific with next-generation sequencing technology

AXELIOS 1 introduces Roche’s proprietary sequencing by expansion (SBX) technology, designed for flexibility and performance to tackle a wide range of sequencing workflows with speed and accuracy

As APAC’s genomics capabilities expand, the platform offers researchers greater freedom to pursue studies of varying scale and complexity

Roche will bring together researchers and laboratory leaders at AXELIOS Days in Australia and South Korea this November to explore the technology’s potential for genomic research

SINGAPORE, Nov. 9, 2026 /PRNewswire/ — Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June 2026. Building on early adoption in South Korea, Roche will bring the transformative technology closer to researchers and laboratory leaders across the region through AXELIOS Days in Sydney and Seoul this November.